Sun Pharmaceutical subsidiary acquires Alchemee business from Galderma

Sun Pharmaceutical Industries said that its subsidiary Taro Pharmaceutical Industries‘ fully-owned subsidiary Taro Pharmaceuticals U.S.A., has acquired Delaware-based Galderma Holdings, Japan-based Proactiv YK, Canada-based The Proactiv Company, and other assets of The Proactiv Company Sari.

The consideration for the deal is $99.28 million.

Galderma Holdings, which is incorporated in Delaware, Proactiv YK, The Proactiv Company, and The Proactiv Company Sari are all subsidiary companies of Galderma.

Through the deal, Taro Pharmaceuticals will acquire the business of developing, manufacturing, marketing, selling and distributing products sold under the Proactiv, Restorative Elements and In Defense of Skin brands (together, called the Alchemee business).